Literature DB >> 18727915

NS5ATP9 gene regulated by NF-kappaB signal pathway.

Kang Li1, Qingyong Ma, Lei Shi, Chengxue Dang, Yuan Hong, Qi Wang, Yue Li, Wanhu Fan, Lei Zhang, Jun Cheng.   

Abstract

NS5ATP9 was previously identified as p15 PAF [proliferating cell nuclear antigen (PCNA)-associated factor] to bind with PCNA. We earlier identified the promoter region of NS5ATP9 and found NS5ATP9 is a NS5A up-regulation gene. However little is known about how it is regulated. To investigate the gene regulation of NS5ATP9, we screened NS5ATP9 promoter binding proteins using phage display and verified by electrophoretic mobility shift assay (EMSA). We found that the nuclear protein rhNF-kappaB (p50) could bind to the NS5ATP9 promoter and the binding region contained within a 156 bp (nucleotides -5 to -161bp) immediately upstream of the transcription initiation site. Our results suggest that NF-kappaB could participate in the regulation of NS5ATP9 gene expression in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18727915     DOI: 10.1016/j.abb.2008.08.005

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Alternation of gene expression in trigeminal ganglion neurons following complete Freund's adjuvant or capsaicin injection into the rat face.

Authors:  Masayo Okumura; Koichi Iwata; Koichi Yasuda; Katsuhiro Inoue; Masamichi Shinoda; Kuniya Honda; Kazuo Shibuta; Masashi Yasuda; Eiji Kondo
Journal:  J Mol Neurosci       Date:  2010-03-28       Impact factor: 3.444

2.  TAF and TDF attenuate liver fibrosis through NS5ATP9, TGFβ1/Smad3, and NF-κB/NLRP3 inflammasome signaling pathways.

Authors:  Jing Zhao; Ming Han; Li Zhou; Pu Liang; Yun Wang; Shenghu Feng; Hongping Lu; Xiaoxue Yuan; Kai Han; Xiaofan Chen; Shunai Liu; Jun Cheng
Journal:  Hepatol Int       Date:  2019-11-22       Impact factor: 6.047

3.  NS5ATP9 suppresses activation of human hepatic stellate cells, possibly via inhibition of Smad3/phosphorylated-Smad3 expression.

Authors:  Mengran Zhang; Jinqian Zhang; Shunai Liu; Qi Wang; Guoxian Lin; Rongxian Qiu; Min Quan; Jun Cheng
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

4.  Analysis of schizophrenia and hepatocellular carcinoma genetic network with corresponding modularity and pathways: novel insights to the immune system.

Authors:  Kuo-Chuan Huang; Ko-Chun Yang; Han Lin; Theresa Tsao Tsun-Hui; Wen-Kuei Lee; Sheng-An Lee; Cheng-Yan Kao
Journal:  BMC Genomics       Date:  2013-10-16       Impact factor: 3.969

5.  Paf15 expression correlates with rectal cancer prognosis, cell proliferation and radiation response.

Authors:  Rong Yan; Kun Zhu; Chengxue Dang; Ke Lan; Haonan Wang; Dawei Yuan; Wei Chen; Stephen J Meltzer; Kang Li
Journal:  Oncotarget       Date:  2016-06-21

6.  PCNA-associated factor (KIAA0101/PCLAF) overexpression and gene copy number alterations in hepatocellular carcinoma tissues.

Authors:  Anchalee Tantiwetrueangdet; Ravat Panvichian; Pattana Sornmayura; Surasak Leelaudomlipi; Jill A Macoska
Journal:  BMC Cancer       Date:  2021-03-20       Impact factor: 4.430

7.  NS5ATP9 contributes to inhibition of cell proliferation by hepatitis C virus (HCV) nonstructural protein 5A (NS5A) via MEK/extracellular signal regulated kinase (ERK) pathway.

Authors:  Qi Wang; Yongsheng Wang; Yue Li; Xuesong Gao; Shunai Liu; Jun Cheng
Journal:  Int J Mol Sci       Date:  2013-05-21       Impact factor: 5.923

8.  Microarray analysis reveals Tmub1 as a cell cycle-associated protein in rat hepatocytes.

Authors:  Hangwei Fu; Jianhua Xu; Jian Chen; Guangyao Li; Xiaobiao Zhao; Ping Chen
Journal:  Mol Med Rep       Date:  2018-01-17       Impact factor: 2.952

9.  Prognostic value and underlying mechanism of KIAA0101 in hepatocellular carcinoma: database mining and co-expression analysis.

Authors:  Weiyu Xu; Xuezhu Wang; Xiaoqian Wu; Si Yu; Jianping Xiong; Xinting Sang; Yongchang Zheng; Zhongtao Zhang
Journal:  Aging (Albany NY)       Date:  2020-08-27       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.